BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2025.
Artif Intell Med Imaging. Sep 8, 2025; 6(2): 108032
Published online Sep 8, 2025. doi: 10.35711/aimi.v6.i2.108032
Table 3 Chemotherapeutic agents commonly used for glioblastoma multiforme
Drug
Dose
Ref.
Temozolomide75 mg/m2 daily and 150-200 mg/m2 (5/28 days)[106]
Bevacizumab10 mg/kg every 2 weeks[110]
Procarbazine110 mg/m2 day 1/56[113]
Vincristine1.4 mg/m2 days 8 and 29/56[113]
Lomustine (CCNU)60 mg/m2 days 8-21/56[114]


Write to the Help Desk